These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 11800085

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A large-scale, prospective, observational study of leukocytapheresis for ulcerative colitis: treatment outcomes of 847 patients in clinical practice.
    Yokoyama Y, Matsuoka K, Kobayashi T, Sawada K, Fujiyoshi T, Ando T, Ohnishi Y, Ishida T, Oka M, Yamada M, Nakamura T, Ino T, Numata T, Aoki H, Sakou J, Kusada M, Maekawa T, Hibi T.
    J Crohns Colitis; 2014 Sep; 8(9):981-91. PubMed ID: 24556083
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Leukocytapheresis is effective in inducing but not in maintaining remission in ulcerative colitis.
    Honma T, Sugimura K, Asakura H, Matsuzawa J, Suzuki K, Kobayashi M, Aoyagi Y.
    J Clin Gastroenterol; 2005 Sep; 39(10):886-90. PubMed ID: 16208112
    [Abstract] [Full Text] [Related]

  • 7. LEUKOCYTAPHERESIS IN THE MANAGEMENT OF SEVERE STEROID-DEPENDENT ULCERATIVE COLITIS.
    Krznarić Ž, Markoš P, Golubić Ćepulić B, Čuković-Čavka S, Domislović V, Bojanić I, Barišić A, Kekez D.
    Acta Clin Croat; 2019 Sep; 58(3):529-534. PubMed ID: 31969767
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Mobilization of bone marrow cells by leukocytapheresis in patients with ulcerative colitis.
    Mitsuyama K, Andoh A, Masuda J, Yamasaki H, Kuwaki K, Takedatsu H, Seki R, Nishida H, Tsuruta O, Sata M.
    Ther Apher Dial; 2008 Aug; 12(4):271-7. PubMed ID: 18789113
    [Abstract] [Full Text] [Related]

  • 11. Feasibility of five days of consecutive leukocytapheresis for the treatment of ulcerative colitis: a preliminary study.
    Tsujikawa T, Andoh A, Ogaẃa A, Sonoda A, Yagi Y, Hata K, Sasaki M, Saito Y, Fujiyama Y.
    Ther Apher Dial; 2009 Feb; 13(1):14-8. PubMed ID: 19379165
    [Abstract] [Full Text] [Related]

  • 12. Leukocytapheresis for the treatment of IBD.
    Sigurbjörnsson FT, Bjarnason I.
    Nat Clin Pract Gastroenterol Hepatol; 2008 Sep; 5(9):509-16. PubMed ID: 18665138
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A multicenter study of the efficacy and safety of leukocytapheresis therapy without concomitant systemic steroid treatment in patients with active ulcerative colitis.
    Ashida T, Kohgo Y, Munakata A, Noguchi M, Iizuka B, Endo Y, Hanai H, Yoshikawa T, Matsumoto T, Aoyama N, Matsui T, Mitsuyama K, Hibi T.
    Transfus Apher Sci; 2011 Apr; 44(2):113-7. PubMed ID: 21402309
    [Abstract] [Full Text] [Related]

  • 16. Leukocytapheresis therapy for severe ulcerative colitis.
    Sasaki M, Tsujikawa T, Fujiyama Y, Bamba T.
    Ther Apher; 1998 May; 2(2):101-4. PubMed ID: 10225708
    [Abstract] [Full Text] [Related]

  • 17. Predictive factors of efficacy of leukocytapheresis for steroid-resistant ulcerative colitis patients.
    Takemoto K, Kato J, Kuriyama M, Nawa T, Kurome M, Okada H, Sakaguchi K, Shiratori Y.
    Dig Liver Dis; 2007 May; 39(5):422-9. PubMed ID: 17379587
    [Abstract] [Full Text] [Related]

  • 18. Ratio of platelet reduction is an early predictive factor for the effectiveness of leukocytapheresis for ulcerative colitis patients.
    Takemoto K, Kuriyama M, Kato J, Suzuki H, Ishikawa S, Hiraoka S, Yamamoto K.
    Ther Apher Dial; 2009 Feb; 13(1):6-13. PubMed ID: 19379164
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Predictive factors of response to leukocytapheresis therapy for ulcerative colitis.
    Yajima T, Takaishi H, Kanai T, Iwao Y, Watanabe M, Ishii H, Hibi T.
    Ther Apher; 1998 May; 2(2):115-9. PubMed ID: 10225711
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.